Minoru Yamamoto
28Patents
4h-index
47Co-inventors
63Inventor score
Filing activity: Aug 25, 1980 → May 31, 2018
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US4564609A | 4-Substituted-2-azetidinone compound, process of producing the compounds, and medicaments containing the compounds | Chemistry; Metallurgy | 22 | Expired |
| US4719207A | CNS active substituted azetidinone compounds | Chemistry; Metallurgy | 6 | Expired |
| US7544703B2 | Cyclic compound having 4-pyridylalkylthio group having substituted or unsubstituted amino group introduced therein | Chemistry; Metallurgy | 5 | Expired |
| US4610821A | 4-substituted-2-azetidinone compound, process of producing the compounds, and medicaments containing the compounds | Chemistry; Metallurgy | 4 | Expired |
| US7473801B2 | Method for purification of amino acid | Chemistry; Metallurgy | 3 | Expired |
| US4636567A | 4-substituted-2-azetidinone compound | Chemistry; Metallurgy | 3 | Expired |
| US8017775B2 | 1-2-dihydroquinoline derivative having glucocorticoid receptor binding activity | Chemistry; Metallurgy | 2 | Active |
| US8551991B2 | 1,2,3,4-tetrahydroquinoxaline derivative having glucocorticoid receptor binding activity | Chemistry; Metallurgy | 2 | Active |
| US8088817B2 | Pyrrole derivative having, as substituents, ureido group, aminocarbonly group and bicyclic group which may have substituent | Chemistry; Metallurgy | 1 | Active |
| US8193237B2 | Indole derivative having IκB kinase β inhibitory activity | Chemistry; Metallurgy | 1 | Active |
| US7906511B2 | Cyclic compound having pyrimidinylalkylthio group | Chemistry; Metallurgy | 1 | Active |
| US7534802B2 | Compounds having 4-pyridylalkylthio group as substituent | Chemistry; Metallurgy | 1 | Expired |
| US7977371B2 | Pyrrole derivative having ureido group and aminocarbonyl group as substituents | Chemistry; Metallurgy | 1 | Active |
| US4297356A | Memory enhancer containing 2-(7-indenyloxymethyl-morpholine | Human Necessities | 1 | Expired |
| US8445529B2 | Indole derivative having, carbamoyl group, ureido group and substituted oxy group | Chemistry; Metallurgy | 1 | Active |
| US8076332B2 | N- (2-aminophenyl) benzamide derivative having urea structure | Chemistry; Metallurgy | 1 | Active |
| US8975256B2 | 1,2,3,4-tetrahydroquinoxaline compounds having glucocorticoid receptor binding activity | Chemistry; Metallurgy | 0 | Active |
| US8288380B2 | Thiophenediamine derivative having urea structure | Chemistry; Metallurgy | 0 | Active |
| US8518973B2 | Compounds having 4-pyridylalkylthio group as a substituent | Chemistry; Metallurgy | 0 | Active |
| US8012972B2 | Pyridinecarboxylic acid (2-aminophenyl) amide derivative having urea structure | Chemistry; Metallurgy | 0 | Active |
| US11186588B2 | 6H-thieno[2,3-e][1,2,4]triazolo[3,4-c][1,2,4]triazepine derivative | Human Necessities | 0 | Active |
| US8420635B2 | Method for preventing or treating a glucocorticoid receptor-related disease | Chemistry; Metallurgy | 0 | Active |
| US7897774B2 | Cyclic compound having quinolylalkylthio group | Chemistry; Metallurgy | 0 | Active |
| US8207194B2 | Compounds having a 4-pyridylalkylthio group as a substituent | Chemistry; Metallurgy | 0 | Active |
| US4609656A | Medical agent for improving and treating mental symptoms induced by cerebral disturbances | Human Necessities | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.